TYCC
PDLI

Texas Yale Capital Corp’s PDL BioPharma, Inc. PDLI Stock Holding History

Texas Yale Capital Corp’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-38,150
Closed -$369K – 442
2014
Q2 		$369K Hold
38,150
– – 0.05% 293
2014
Q1 		$317K Hold
38,150
– – 0.04% 298
2013
Q4 		$322K Hold
38,150
– – 0.05% 237
2013
Q3 		$304K Hold
38,150
– – 0.05% 241
2013
Q2 		$295K Buy
+38,150
New +$297K 0.05% 224

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Texas Yale Capital Corp's PDLI Position: Q3 2014 in Review

Texas Yale Capital Corp sold out of PDL BioPharma, Inc. (PDLI) in Q3 2014, closing a stake of 38,150 shares — an estimated $369K sold.

Texas Yale Capital Corp first reported a position in PDLI in Q2 2013 and held it in 5 quarters. The position peaked at $369K in Q2 2014. 231 funds tracked by Wall St. Rank hold PDLI as of Q3 2014.

  • Texas Yale Capital Corp reported no remaining PDL BioPharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Texas Yale Capital Corp sold 38,150 PDL BioPharma, Inc. shares in Q3 2014, an estimated $369K.
  • Texas Yale Capital Corp first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 5 quarters.
  • Texas Yale Capital Corp's PDL BioPharma, Inc. position peaked at $369K in Q2 2014.
  • 231 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2014.

Based on Texas Yale Capital Corp's 13F filing for Q3 2014, filed 13 Nov 2014.